Pharmaceutical Market Europe

News & analysis of healthcare, pharma and biotech. Magazines, directories, profiles, jobs & awards.

[Pharmaceutical Market Europe @PMLiVEcom]

Gilead’s New Drug Application for Yeztugo accepted by US FDA https://t.co/5l3I6LvEJ7

[Pharmaceutical Market Europe @PMLiVEcom]

Medscape Education Recognized With 2 Spring 2026 Digital Health Awards for Excellence in Clinical Education https://t.co/RPJkZNSP2v

[Pharmaceutical Market Europe @PMLiVEcom]

Ultomiris gets US FDA Priority Review for immunoglobulin A nephropathy treatment https://t.co/67o8ilaF3i

[Pharmaceutical Market Europe @PMLiVEcom]

Obesity care in the UK – why it can’t improve until it is recognised as a disease https://t.co/ohX2Ymk4Z8

[Pharmaceutical Market Europe @PMLiVEcom]

Novo Nordisk’s Wegovy approved as UK’s first daily GLP-1 weight loss pill https://t.co/mLaaKwQV1M

[Pharmaceutical Market Europe @PMLiVEcom]

How to build a commercialisation strategy fit for biopharma’s new evidence era https://t.co/w7HA6mK2m8

[Pharmaceutical Market Europe @PMLiVEcom]

Roche’s Tecentriq gets FDA Priority Review for specific stage 3 colon cancer https://t.co/kLkl982XN1

[Pharmaceutical Market Europe @PMLiVEcom]

New benchmark reveals significant digital maturity gap across UK POM companies’ product-information estates https://t.co/Oz5R3l9lGA

[Pharmaceutical Market Europe @PMLiVEcom]

Lilly’s Ebglyss approved by FDA as maintenance dose for atopic dermatitis https://t.co/mNMyhUWpXn

[Pharmaceutical Market Europe @PMLiVEcom]

Where translation falls short in practice https://t.co/vIpeJUMPdy

[Pharmaceutical Market Europe @PMLiVEcom]

GSK to acquire biopharma Nuvalent for $10.6bn https://t.co/h2eGleYelW

[Pharmaceutical Market Europe @PMLiVEcom]

Roche and Nurix Therapeutics to partner in $2.3bn deal https://t.co/hpqheRjteR

[Pharmaceutical Market Europe @PMLiVEcom]

Headline trade and market deals are opening doors to greater patient access https://t.co/ucNhRFgbiv

[Pharmaceutical Market Europe @PMLiVEcom]

Biogen’s salanersen gets FDA Breakthrough Therapy Designation for SMA https://t.co/qjQYa9fTdb

[Pharmaceutical Market Europe @PMLiVEcom]

Ardena appoints Ariane de Ganck as Chief Scientific Officer https://t.co/CBFPsUDDU7

[Pharmaceutical Market Europe @PMLiVEcom]

Alnylam and Inceptive agree on $2bn AI collaboration https://t.co/dftfaLfOtW

[Pharmaceutical Market Europe @PMLiVEcom]

The Words Around Health Matter https://t.co/Qtko35hAAz

[Pharmaceutical Market Europe @PMLiVEcom]

Bristol Myers Squibb and SystImmune announce phase 3 results for antibody-drug conjugate https://t.co/tlFqawzywY

[Pharmaceutical Market Europe @PMLiVEcom]

From activity to impact: 5 takeaways from MAPS Americas 2026 https://t.co/QMh9uriTuf

[Pharmaceutical Market Europe @PMLiVEcom]

Medscape Education Brings AI to the Hematology Frontline at EHA 2026 https://t.co/wcfBSHYh9b